Institution
Fourth Hospital of Hebei Medical University
Also known as: Tumor Hospital of Hebei · 河北医科大学第四医院
- 117running trials
- 28closed trials
- 10,048publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
Recruiting
Recruiting
Not yet recruiting
Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC
Recruiting
Recruiting
Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer
Not yet recruiting
Not yet recruiting
A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer
Recruiting
Recruiting
DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)
Recruiting
Not yet recruiting
Not yet recruiting
ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy
Recruiting
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
Active, not recruiting
HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Recruiting
Recruiting
Recruiting
Recruiting
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer(Neo-Color)
Recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Showing 50 of 117.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer27 recruiting
- Lung cancer21 recruiting
- Metastatic breast cancer8 recruiting
- Colorectal cancer6 recruiting
- Childhood cancers4 recruiting
- Liver and biliary tract cancer4 recruiting
- Triple-negative breast cancer3 recruiting
- Brain metastases2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Head and neck cancer2 recruiting
- Mantle cell lymphoma2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Pancreatic cancer1 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Completed
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
Terminated
IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Completed
Completed
Completed
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Completed
Completed
Completed
Completed
Completed
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Completed
Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors
Withdrawn
Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC
Completed
Completed
Completed
Completed
Completed
Registry name variants (12)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
The Fourth Hospital of Hebei Medical University
Shijiazhuang, 050000
108 trials
Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei 050035
14 trials
Hebei Medical University Fourth Hospital
Shijiazhuang, Hebei 050000
12 trials
The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital)
Shijiazhuang, Hebei 050011
3 trials
Contact: Chao Li
NCT06056115Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
Contact: Jian Shi, Dr.
Contact: Cuizhi Geng
Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei 050011
1 trial
Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei 050011
1 trial
Fourth Hospital of Hebei Medical University (Site 0331)
Shijiazhuang, Hebei 050035
1 trial
Fourth Hospital of Hebei Medical University (Site 0633)
Shijiazhuang, Hebei 050035
1 trial
Fourth Hospital of Hebei Medical University (Site 2201)
Shijiazhuang, Hebei 050011
1 trial
Contact: Study Coordinator
Fourth Hospital Of Hebei Medical University (Site 2436)
Shijiazhuang, Hebei 050011
1 trial
Fourth Hospital Of Hebei Medical University (Site 2441)
Shijiazhuang, Hebei 050011
1 trial
Fourth Hospital of Hebei Medical University (Site 3015)
Shijiazhuang, Hebei 050035
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer108 works · 33 trials
- Gastric and oesophageal cancer104 works · 42 trials
- Ovarian cancer31 works · 2 trials
- Brain metastases13 works · 2 trials
- Diffuse large B-cell lymphoma10 works · 4 trials
Institution data: ROR 01mdjbm03 (CC0-1.0)Updated 15 Nov 2026